Valuation: ResMed, Inc.

Market Cap 30.14B 26.48B 24.72B 22.69B 42.47B 2,887B 43.52B 293B 115B 1,429B 113B 111B 4,939B P/E 2026 *
19.7x
P/E 2027 * 18.4x
Enterprise Value 29.31B 25.76B 24.04B 22.07B 41.3B 2,808B 42.32B 285B 111B 1,389B 110B 108B 4,803B EV / Sales 2026 *
5.19x
EV / Sales 2027 * 4.77x
Free-Float
75.61%
Yield 2026 *
1.16%
Yield 2027 * 1.25%
1 day+2.46%
1 week+10.85%
Current month+9.73%
1 month+7.77%
3 months+0.90%
6 months-16.99%
Current year-11.22%
1 week 190.21
Extreme 190.21
215.2
1 month 190.21
Extreme 190.21
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06/26 Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.01%+10.85%-22.99%-3.83% 30.14B
-0.65%+8.92%+18.93%+4.51% 214B
-1.24%+10.56%-4.25%-22.35% 140B
-2.40%+3.93%-28.74%+9.15% 128B
-0.08%+7.81%-56.49%-10.66% 68.46B
+2.24%+1.53%+6.45%+4.37% 48.18B
+4.51%+8.59%-22.65%-28.93% 45.56B
-0.23%+5.16%+17.11%+15.26% 39.69B
-0.98%+2.53%+25.40%+37.65% 37.69B
+1.38%+2.45%+79.88%+1.77% 29.2B
Average +0.77%+4.32%+1.27%+0.70% 78.09B
Weighted average by Cap. +0.08%+5.19%-1.95%-1.11%

Financials

2026 *2027 *
Net sales 5.65B 4.97B 4.63B 4.25B 7.96B 541B 8.16B 54.96B 21.49B 268B 21.22B 20.75B 926B 5.97B 5.24B 4.89B 4.49B 8.41B 572B 8.62B 58.04B 22.7B 283B 22.41B 21.92B 978B
Net income 1.55B 1.36B 1.27B 1.16B 2.18B 148B 2.23B 15.04B 5.88B 73.29B 5.81B 5.68B 253B 1.61B 1.42B 1.32B 1.21B 2.27B 154B 2.33B 15.67B 6.13B 76.38B 6.05B 5.92B 264B
Net Debt -827M -726M -678M -622M -1.16B -79.18B -1.19B -8.04B -3.14B -39.18B -3.1B -3.04B -135B -1.65B -1.45B -1.35B -1.24B -2.32B -158B -2.38B -16.01B -6.26B -78.04B -6.18B -6.05B -270B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
29/07/26 $213.71 +2.27% 574,741
28/07/26 $208.96 +2.90% 1,137,281
27/07/26 $203.08 +4.00% 1,142,770
24/07/26 $195.27 +1.76% 1,005,232
23/07/26 $191.89 -0.53% 1,012,467
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
208.96USD
Average target price
248.60USD
Spread / Average Target
+18.97%

Quarterly revenue - Rate of surprise